Search
tavaborole (Kerydin)
Indications:
- onychomycosis of the toenails
Dosage:
- apply solution with dropper to affected toenails once daily for 48 weeks
Solution: 5%
Adverse effects:
- exfoliation
- ingrown toenail
- erythema
- dermatitis
Notes:
- complete cure at 52 weeks: 7-9% vs < 1.5% with placebo [1]
General
antifungal agent
topical agent
Database Correlations
PUBCHEM cid=11499245
References
- Anocor News Release. July 8, 2014
FDA Approves Anacor Pharmaceuticals' KERYDIN (Tavaborole)
Topical Solution, 5% for the Treatment of Onychomycosis of the
Toenails.
http://investor.anacor.com/releasedetail.cfm?ReleaseID=858211